W. Thomas London, MD - Internal Medicine/Hepatology
W. Thomas London, MD - Internal Medicine/Hepatology
Dr. W. Thomas London, MD reviews medical content for Healthwise, a
nonprofit organization with a mission to help people make better health
decisions. Dr. London is a senior member in the Division of Population Science
and director of the Liver Cancer Prevention Center at the Fox Chase Cancer
Center and is widely published in peer-reviewed publications.
Dr. London received the Distinguished Scientist Award in 1998 from
the Hepatitis B Foundation in Doylestown, Pennsylvania, and the Distinguished
Interdisciplinary Research Award in 1999 from the American Cancer Society,
Southeast Region.
Dr. London is a member of the Board of Directors of the Hepatitis B
Foundation in Doylestown and is also a member of the foundation's Medical
Advisory Board. He is a member of the Boards Institute for Virus and Hepatitis
Research and the Pennsylvania BioTechnology Center, also located in
Doylestown.
Board Certifications
American Board of Internal Medicine
Healthwise Knowledgebase Topics Reviewed
Hepatitis (A,B and
C)
Nonalcoholic Steatohepatitis (NASH)
Education
MD: Cornell University Medical College, New
York, NY, 1957
Internship: Bellevue Hospital, 2nd Cornell Medical
Division, New York, NY, 1957-1958
Residency: Medicine, Bellevue
Hospital, 2nd Medical Division and Memorial Center (Combined Program),
1958-1960
Fellowship: Research Fellowship in Medicine
(Endocrinology) Sloan-Kettering Institute, New York, NY, 1960-1962
Academic Appointments
Senior Member, Division of Population
Science, Fox Chase Cancer Center, Philadelphia, PA, 1990-present
Adjunct Professor of Epidemiology, Center for Clinical
Epidemiology and Biostatistics, University of Pennsylvania School of Medicine,
Philadelphia, 1999-present
Hospital Affiliations
Fox Chase Cancer Center, Philadelphia,
PA
Professional Affiliations
American Association for Cancer
Research
American Association for the Advancement of
Science
American Board of Internal Medicine
American
College of Physicians
American Liver Foundation
American Medical Association
American Society for
Virology
American Society of Preventive Oncology
Hepatitis B Foundation
Philadelphia County Medical Society
Philadelphia Epidemiology Society
Selected Publications
Evans AA, O'Connell AP, Mason WS, M'boup S,
Shen FM, London WT (In press). Heterogeneity of the pre-C/C region of hepatitis
B virus (HBV) in chronic carriers from China and West Africa. In J Margolis et
al., eds., Viral Hepatitis and Liver Disease. London:
International Medical Press.
Gao LL, Chen G, Evans AA, Lin WY,
O'Connell AP, Propert KJ, Williams S, Shen FM, London WT, Haimen City
Cooperating Group (In press). Predicting hepatocellular carcinoma: A model
developed from a 4-year prospective study of hepatitis B virus carriers. In H
Margolis et al., eds., Viral Hepatitis and Liver Disease. London: International Medical Press.
McGlynn KA,
Edmondson MN, Michielli RA, London WT, Lin WY, Shen FM, Buetow KH (2002). A
phylogenetic analysis of loss of heterozygosity in hepatocellular carcinoma.
Hepatology, 36(6): 1341-1348.
Evans AA,
Chen G, Ross EA, Shen FM, Lin WY, London WT (2002). Eight-year follow-up of the
90,000-person Haimen City Cohort: I . Hepatocellular carcinoma mortality, risk
factors, and gender differences. Cancer Epidemiology Biomarkers and Prevention, 11(4): 369-376.
London WT (2002). Liver
cancer: Etiology and prevention. In J Bertino et al., eds., Encyclopedia of Cancer, 2nd ed. San Diego: Academic
Press.
Balsara BR, Pei J, De Rienzo A, Simon D, Tosolini A, Lu YY,
Shen FM, Fan X, Lin WY, Buetow KH, London WT, Testa JR (2001). Human
hepatocellular carcinoma is characterized by a highly consistent pattern of
genomic imbalances, including frequent loss of 16q23.1-24.1. Genes, Chromosomes, and Cancer, 30(3): 245-253.
Steel LF, Mattu TS, Mehta A, Hebesteit H, Dwek R, Evans A, London WT, Block T
(2001). A proteomic approach for the discovery of early detection markers of
hepatocellular carcinoma. Disease Markers, 17(3):
179-189.
